Find out how to support your lungs and encourage recovery from smoking-related damage.
Hydrogen therapy shows promise in treating lung injuries and diseases by targeting mitochondrial dysfunction, inflammation, and oxidative stress, which are key factors in the progression of conditions like septic lung injury and viral pneumonia.
Hydrogen therapy helps to restore mitochondrial function, reduce inflammation, and enhance autophagy (the break down and reusing of old cell parts so that cells can operate more efficiently), thereby mitigating lung injury in conditions such as septic lung injury and viral pneumonia. It also improves energy metabolism and enhances mitophagy (the removal of damaged mitochondria through autophagy), which alleviates organ injury.
Yes, hydrogen therapy has been shown to reduce inflammation and oxidative stress, thereby attenuating I/R injury in lung transplantation and other causes. It decreases the release of proinflammatory cytokines and modulates inflammatory response pathways like the p38MAPK and NF-κB pathways.
Studies show that hydrogen therapy can reduce oxidative stress and inflammation in COPD and asthma, leading to improved lung function and decreased airway inflammation. It also inhibits epithelial-mesenchymal transition (EMT), which plays a crucial role in airway remodeling and fibrosis.
Initial research is positive with studies showing hydrogen therapy demonstrating anticancer effects by downregulating pro-proliferative and antiapoptotic pathways, enhancing the immune response, and improving the efficacy of conventional cancer therapies. It activates exhausted CD8+ T cells and promotes apoptosis in lung cancer cells.
Hydrogen therapy can be administered through inhalation of hydrogen gas, oral intake of hydrogen-rich water, or injection of hydrogen saline via various routes such as peritoneal, intravenous, intrathecal, or intratracheal. Topical formulations or eye drops are also possible administration methods.
Nanomedicine strategies involving targeted delivery and controlled release of hydrogen show promise in improving treatment efficacy, particularly in lung cancer. These methods can provide tumor-targeted delivery and controlled release of bio-reductive hydrogen, thus enhancing therapeutic outcomes.
Hydrogen therapy demonstrates significant protective effects on lung health by modulating oxidative stress, inflammation, and cell death pathways. While animal experiments and clinical trials have shown promising results, further large-scale clinical trials are needed to confirm its therapeutic efficacy and safety for human use.
